Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities.

By Pimprapa Vejpongsa, E. Yeh. Journal of the American College of Cardiology, 2014

626 citations recorded by the source corpus.

Subfields: Cardiology and Cardiovascular Medicine, Oncology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/199e606927ccb20110ac2d1fbaf8986901225360

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cardiology and Cardiovascular Medicine

1. Gregory Y. H. Lip
2. Jose Luis Zamorano
3. D. Lenihan
4. P. Lancellotti

Citations in the corpus

• 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines:  The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC). (2016, background): “For a detailed discussion of the cellular and molecular mechanisms, the reader is referred to two reviews.(32,33) The cardiotoxicity of anthracyclines may be acute, early or late.”